These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28780023)

  • 61. Disease-causing allele-specific silencing against the ALK2 mutants, R206H and G356D, in fibrodysplasia ossificans progressiva.
    Takahashi M; Katagiri T; Furuya H; Hohjoh H
    Gene Ther; 2012 Jul; 19(7):781-5. PubMed ID: 22130450
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A fibrodysplasia ossificans progressiva patient with a rare missense mutation in ACVR1 detected on
    Ni H; Tang S; Zhang Y
    Joint Bone Spine; 2024 Mar; 91(2):105682. PubMed ID: 38159793
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification and characterization of regulatory elements in the promoter of ACVR1, the gene mutated in Fibrodysplasia Ossificans Progressiva.
    Giacopelli F; Cappato S; Tonachini L; Mura M; Di Lascio S; Fornasari D; Ravazzolo R; Bocciardi R
    Orphanet J Rare Dis; 2013 Sep; 8():145. PubMed ID: 24047559
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Symmetrical glial hyperplasia in the brainstem of fibrodysplasia ossificans progressiva.
    Mori S; Suzuki SO; Honda H; Hamasaki H; Sakae N; Sasagasako N; Furuya H; Iwaki T
    Neuropathology; 2021 Apr; 41(2):146-151. PubMed ID: 33404144
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ACVR1
    Haupt J; Stanley A; McLeod CM; Cosgrove BD; Culbert AL; Wang L; Mourkioti F; Mauck RL; Shore EM
    Mol Biol Cell; 2019 Jan; 30(1):17-29. PubMed ID: 30379592
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date.
    Gregson CL; Hollingworth P; Williams M; Petrie KA; Bullock AN; Brown MA; Tobias JH; Triffitt JT
    Bone; 2011 Mar; 48(3):654-8. PubMed ID: 21044902
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Genetic basis for skeletal disease. Establishment of novel treatments for fibrodysplasia ossificans progressiva (FOP)].
    Katagiri T
    Clin Calcium; 2010 Aug; 20(8):1204-11. PubMed ID: 20675931
    [TBL] [Abstract][Full Text] [Related]  

  • 68. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.
    van Dinther M; Visser N; de Gorter DJ; Doorn J; Goumans MJ; de Boer J; ten Dijke P
    J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Induced Pluripotent Stem Cells to Model Human Fibrodysplasia Ossificans Progressiva.
    Cai J; Orlova VV; Cai X; Eekhoff EMW; Zhang K; Pei D; Pan G; Mummery CL; Ten Dijke P
    Stem Cell Reports; 2015 Dec; 5(6):963-970. PubMed ID: 26626181
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Design of primers for direct sequencing of nine coding exons in the human ACVR1 gene.
    Matsuoka M; Tsukamoto S; Orihara Y; Kawamura R; Kuratani M; Haga N; Ikebuchi K; Katagiri T
    Bone; 2020 Sep; 138():115469. PubMed ID: 32512165
    [TBL] [Abstract][Full Text] [Related]  

  • 71. ACVR1 gene mutation in sporadic Korean patients with fibrodysplasia ossificans progressiva.
    Lee DY; Cho TJ; Lee HR; Park MS; Yoo WJ; Chung CY; Choi IH
    J Korean Med Sci; 2009 Jun; 24(3):433-7. PubMed ID: 19543505
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Suppressed prefrontal cortex oscillations associate with clinical pain in fibrodysplasia ossificans progressiva.
    Peng K; Karunakaran KD; Labadie R; Veliu M; Cheung C; Lee A; Yu PB; Upadhyay J
    Orphanet J Rare Dis; 2021 Jan; 16(1):54. PubMed ID: 33516233
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Zebrafish Model of Human Fibrodysplasia Ossificans Progressiva.
    LaBonty M; Pray N; Yelick PC
    Zebrafish; 2017 Aug; 14(4):293-304. PubMed ID: 28394244
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Limb specific Acvr1-knockout during embryogenesis in mice exhibits great toe malformation as seen in Fibrodysplasia Ossificans Progressiva (FOP).
    Hildebrand L; Schmidt-von Kegler M; Walther M; Seemann P; Stange K
    Dev Dyn; 2019 May; 248(5):396-403. PubMed ID: 30854720
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Activin-dependent signaling in fibro/adipogenic progenitors causes fibrodysplasia ossificans progressiva.
    Lees-Shepard JB; Yamamoto M; Biswas AA; Stoessel SJ; Nicholas SE; Cogswell CA; Devarakonda PM; Schneider MJ; Cummins SM; Legendre NP; Yamamoto S; Kaartinen V; Hunter JW; Goldhamer DJ
    Nat Commun; 2018 Feb; 9(1):471. PubMed ID: 29396429
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Horizon of a Therapy for Rare Genetic Diseases: A "Druggable" Future for Fibrodysplasia Ossificans Progressiva.
    Cappato S; Giacopelli F; Ravazzolo R; Bocciardi R
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587443
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acute and chronic rapamycin use in patients with Fibrodysplasia Ossificans Progressiva: A report of two cases.
    Kaplan FS; Zeitlin L; Dunn SP; Benor S; Hagin D; Al Mukaddam M; Pignolo RJ
    Bone; 2018 Apr; 109():281-284. PubMed ID: 29241828
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva.
    Hino K; Horigome K; Nishio M; Komura S; Nagata S; Zhao C; Jin Y; Kawakami K; Yamada Y; Ohta A; Toguchida J; Ikeya M
    J Clin Invest; 2017 Sep; 127(9):3339-3352. PubMed ID: 28758906
    [TBL] [Abstract][Full Text] [Related]  

  • 79. International physician survey on management of FOP: a modified Delphi study.
    Di Rocco M; Baujat G; Bertamino M; Brown M; De Cunto CL; Delai PLR; Eekhoff EMW; Haga N; Hsiao E; Keen R; Morhart R; Pignolo RJ; Kaplan FS
    Orphanet J Rare Dis; 2017 Jun; 12(1):110. PubMed ID: 28606101
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multi-omics therapeutic perspective on ACVR1 gene: from genetic alterations to potential targeting.
    Nagar G; Mittal P; Gupta SRR; Pahuja M; Sanger M; Mishra R; Singh A; Singh IK
    Brief Funct Genomics; 2023 Apr; 22(2):123-142. PubMed ID: 36003055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.